NASDAQ: MENS
Jyong Biotech Ltd Stock Ownership - Who owns Jyong Biotech?

Insider buying vs selling

Have Jyong Biotech Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when MENS insiders and whales buy or sell their stock.

MENS Shareholders

What type of owners hold Jyong Biotech Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fufeng Kuo33.34%25,349,500$45.63MInsider
Ming Tsan Hsu0.00%3,000$5.40kInsider
Fenglin Hsu0.00%3,000$5.40kInsider
Blackrock Inc0.00%284$511.20Institution
Geode Capital Management LLC0.00%73$131.40Institution
Citigroup Inc0.00%21$37.80Institution
Stonex Group Inc0.00%15$27.00Institution
China Universal Asset Management Co Ltd0.00%13$23.40Institution
Morgan Stanley0.00%6$10.80Institution
Barclays PLC0.00%6$10.80Institution

1 of 2

MENS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MENS0.00%33.35%
STRO0.10%91.96%Net SellingNet Selling
RNA0.07%2.41%Net SellingNet Selling
IVVD0.07%31.35%Net Selling
HUMA0.02%11.16%Net BuyingNet Buying

Jyong Biotech Stock Ownership FAQ

Who owns Jyong Biotech?

Jyong Biotech (NASDAQ: MENS) is owned by 0.00% institutional shareholders, 33.35% Jyong Biotech insiders, and 66.65% retail investors. Fufeng Kuo is the largest individual Jyong Biotech shareholder, owning 25.35M shares representing 33.34% of the company. Fufeng Kuo's Jyong Biotech shares are currently valued at $47.15M.

If you're new to stock investing, here's how to buy Jyong Biotech stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.